These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 36896691)

  • 21. To what extent do disease severity and illness perceptions explain depression, anxiety and quality of life in hidradenitis suppurativa?
    Pavon Blanco A; Turner MA; Petrof G; Weinman J
    Br J Dermatol; 2019 Feb; 180(2):338-345. PubMed ID: 30171696
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Contribution of Malodour in Quality of Life of Patients With Hidradenitis Suppurativa.
    Alavi A; Farzanfar D; Lee RK; Almutairi D
    J Cutan Med Surg; 2018; 22(2):166-174. PubMed ID: 29231053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psychosocial stress affects the change of mental distress under dermatological treatment-A prospective cohort study in patients with psoriasis.
    Wintermann GB; Bierling AL; Peters EMJ; Abraham S; Beissert S; Weidner K
    Stress Health; 2024 Feb; 40(1):e3263. PubMed ID: 37243509
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stigmatization, a social perception which may have a debilitating impact on hidradenitis suppurativa patients: an observational study.
    Singh R; Kelly KA; Senthilnathan A; Feldman SR; Pichardo RO
    Arch Dermatol Res; 2023 May; 315(4):1049-1052. PubMed ID: 36315267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Uncovering burden disparity: A comparative analysis of the impact of moderate-to-severe psoriasis and hidradenitis suppurativa.
    Hamzavi IH; Sundaram M; Nicholson C; Zivkovic M; Parks-Miller A; Lee J; Yi J; Gu Y; Okun MM; Ganguli A; Arikian SR
    J Am Acad Dermatol; 2017 Dec; 77(6):1038-1046. PubMed ID: 28917381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quality of life and psychosocial impact of scarring and non-scarring alopecia in women.
    Katoulis AC; Christodoulou C; Liakou AI; Kouris A; Korkoliakou P; Kaloudi E; Kanelleas A; Papageorgiou C; Rigopoulos D
    J Dtsch Dermatol Ges; 2015 Feb; 13(2):137-42. PubMed ID: 25597233
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk of psoriasis in people with hidradenitis suppurativa: A systematic review and meta-analysis.
    Gau SY; Preclaro IAC; Wei JC; Lee CY; Kuan YH; Hsiao YP; Juang SE; Ma KS
    Front Immunol; 2022; 13():1033844. PubMed ID: 36532043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Validity of EQ-5D-5L, Skindex-16, DLQI and DLQI-R in patients with hidradenitis suppurativa.
    Gergely LH; Gáspár K; Brodszky V; Kinyó Á; Szegedi A; Remenyik É; Kiss NF; Bató A; Péntek M; Gulácsi L; Sárdy M; Bánvölgyi A; Wikonkál N; Rencz F
    J Eur Acad Dermatol Venereol; 2020 Nov; 34(11):2584-2592. PubMed ID: 32618022
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Depression in patients with hidradenitis suppurativa.
    Onderdijk AJ; van der Zee HH; Esmann S; Lophaven S; Dufour DN; Jemec GB; Boer J
    J Eur Acad Dermatol Venereol; 2013 Apr; 27(4):473-8. PubMed ID: 22339940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coprevalence of Hidradenitis Suppurativa and Psoriasis: Detailed Demographic, Disease Severity and Comorbidity Pattern.
    Pinter A; Sarlak M; Zeiner KN; Malisiewicz B; Kaufmann R; Romanelli M; Koenig A; Chiricozzi A
    Dermatology; 2021; 237(5):759-768. PubMed ID: 33326954
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hidradenitis suppurativa and psychosocial well-being: a cross-sectional survey analysis from the All of Us research program.
    Jain S; Tushe S; Sood A; Yeung H; Orenstein LAV
    Arch Dermatol Res; 2024 Jul; 316(7):445. PubMed ID: 38955839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Associations of Internalized Skin Bias With Age, Adverse Psychopathology, and Health-Related Quality of Life Among Patients With Hidradenitis Suppurativa: A Cross-sectional Analysis.
    Butt M; Rigby A; Leslie DL; Foulke GT; Flamm A; Kirby JS; Chinchilli VM
    JAMA Dermatol; 2022 Apr; 158(4):432-438. PubMed ID: 35293961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Burden of Hidradenitis Suppurativa Signs and Symptoms in Quality of Life: Systematic Review and Meta-Analysis.
    Montero-Vilchez T; Diaz-Calvillo P; Rodriguez-Pozo JA; Cuenca-Barrales C; Martinez-Lopez A; Arias-Santiago S; Molina-Leyva A
    Int J Environ Res Public Health; 2021 Jun; 18(13):. PubMed ID: 34206415
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Measuring Quality of Life in Hidradenitis Suppurativa: Development and Validation of a Disease-specific Patient-reported Outcome Measure for Practice and Research.
    Otten M; Augustin M; Blome C; Topp J; Niklaus M; Hilbring C; Bechara FG; Pinter A; Zouboulis CC; Anzengruber F; Kirsten N
    Acta Derm Venereol; 2023 Jan; 103():adv00859. PubMed ID: 36129249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Burden of Hidradenitis Suppurativa: A Systematic Literature Review of Patient Reported Outcomes.
    Kimball AB; Kirby J; Ingram JR; Tran T; Pansar I; Ciaravino V; Willems D; Lewis-Mikhael AM; Tongbram V; Garg A
    Dermatol Ther (Heidelb); 2024 Jan; 14(1):83-98. PubMed ID: 38183616
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alexithymia, Psychological Distress, and Social Impairment in Patients with Hidradenitis Suppurativa.
    Quinto RM; Sampogna F; Fania L; Ciccone D; Fusari R; Mastroeni S; Iani L; Abeni D
    Dermatology; 2021; 237(1):103-110. PubMed ID: 31743903
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Self-Esteem, Depression, Anxiety and Quality of Life in Patients with Melasma Living in a Sunny Mediterranean Area: Results from a Prospective Cross-Sectional Study.
    Platsidaki E; Efstathiou V; Markantoni V; Kouris A; Kontochristopoulos G; Nikolaidou E; Rigopoulos D; Stratigos A; Gregoriou S
    Dermatol Ther (Heidelb); 2023 May; 13(5):1127-1136. PubMed ID: 36995579
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quality of life in persons living with psoriasis patients.
    Martínez-García E; Arias-Santiago S; Valenzuela-Salas I; Garrido-Colmenero C; García-Mellado V; Buendía-Eisman A
    J Am Acad Dermatol; 2014 Aug; 71(2):302-7. PubMed ID: 24836080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Co-morbidities in inflammatory dermatological diseases. Psoriasis, hidradenitis suppurativa, and cardiovascular risk factors.
    Miller IM
    Dan Med J; 2015 Sep; 62(9):. PubMed ID: 26324088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between Inflammatory Markers and Psychometric Scores in Patients with Hidradenitis Suppurativa.
    Liakou AI; Rotsiamis N; Tsantes AG; Routsi E; Rompoti N; Ioannou P; Mpakosi A; Tsamtsouri L; Agiasofitou E; Kotsafti O; Bonovas S; Katoulis A; Papadavid E; Rigopoulos D
    J Clin Med; 2024 Sep; 13(19):. PubMed ID: 39407854
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.